Septerna, Inc. (SEPN)
38.96
-0.17
(-0.43%)
USD |
NASDAQ |
Oct 01, 13:22
Septerna Price : 38.96 for Oct. 1, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 30, 2026 | 39.13 | 39.85 | 38.49 | 39.13 | 209580.0 |
| Sep 29, 2026 | 39.52 | 39.56 | 38.37 | 39.13 | 564501.0 |
| Sep 28, 2026 | 37.61 | 39.78 | 37.03 | 39.74 | 338338.0 |
| Sep 25, 2026 | 38.34 | 38.34 | 37.35 | 37.77 | 344295.0 |
| Sep 24, 2026 | 38.41 | 38.80 | 37.49 | 38.13 | 293141.0 |
| Sep 23, 2026 | 40.17 | 40.17 | 36.98 | 38.45 | 509720.0 |
| Sep 22, 2026 | 38.78 | 41.09 | 38.74 | 40.38 | 412056.0 |
| Sep 21, 2026 | 38.97 | 39.47 | 38.01 | 38.54 | 252437.0 |
| Sep 18, 2026 | 39.28 | 39.48 | 37.88 | 38.69 | 448204.0 |
| Sep 17, 2026 | 39.38 | 40.52 | 39.00 | 39.50 | 256833.0 |
| Sep 16, 2026 | 39.15 | 40.24 | 37.92 | 38.44 | 304947.0 |
| Sep 15, 2026 | 39.52 | 39.52 | 38.26 | 38.86 | 269622.0 |
| Sep 14, 2026 | 38.66 | 39.95 | 38.51 | 39.55 | 356039.0 |
| Sep 11, 2026 | 37.75 | 40.02 | 37.56 | 38.51 | 354801.0 |
| Sep 10, 2026 | 37.37 | 38.43 | 36.60 | 37.75 | 338724.0 |
| Sep 09, 2026 | 37.15 | 39.40 | 37.15 | 37.97 | 475312.0 |
| Sep 08, 2026 | 36.15 | 38.06 | 36.01 | 37.37 | 309896.0 |
| Sep 04, 2026 | 36.57 | 37.59 | 36.57 | 36.75 | 199667.0 |
| Sep 03, 2026 | 37.72 | 38.20 | 36.46 | 36.80 | 241561.0 |
| Sep 02, 2026 | 37.96 | 38.86 | 37.24 | 37.50 | 263248.0 |
| Sep 01, 2026 | 38.15 | 38.57 | 37.24 | 37.68 | 263952.0 |
| Aug 31, 2026 | 38.71 | 39.10 | 37.39 | 38.15 | 415347.0 |
| Aug 28, 2026 | 40.25 | 40.94 | 38.74 | 38.91 | 385882.0 |
| Aug 27, 2026 | 40.01 | 41.08 | 39.95 | 40.47 | 266544.0 |
| Aug 26, 2026 | 41.08 | 41.36 | 40.12 | 40.25 | 168482.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.15 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0001 |
| Arvinas, Inc. | 7.62 |
| Fulcrum Therapeutics, Inc. | 3.695 |
Price Related Metrics
| PS Ratio | 17.73 |
| Price to Book Value | 4.601 |
| Price to Free Cash Flow | 16.68 |
| Earnings Yield | -1.40% |
| Market Cap | 1.779B |